TTOO - T2 Biosystems, Inc.
| Previous Close | 3.7100 |
| Open | 3.7200 |
| Bid | 3.61 x 1400 |
| Ask | 3.85 x 2900 |
| Day's Range | 3.6300 - 3.7600 |
| 52 Week Range | 2.9400 - 9.9800 |
| Volume | 168,950 |
| Avg. Volume | 292,911 |
| Market Cap | 163.824M |
| Beta (3Y Monthly) | 1.72 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.41 |
| Earnings Date | Feb 12, 2018 - Feb 16, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.21 |
- GlobeNewswire•11 hours ago
T2 Biosystems to Present at the 8th Annual SVB Leerink Global Healthcare Conference
T2 Biosystems, Inc. (TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, president and chief executive officer, is scheduled to present at the 8th Annual SVB Leerink Global Healthcare Conference. Mr. McDonough and John Sprague, chief financial officer, will be available for one-on-one meetings during the conference. The presentation will be webcast live and available for replay, and may be accessed by visiting the Investors/Events & Presentations section of the Company’s website at www.t2biosystems.com.
- GlobeNewswire•yesterday
T2 Biosystems Announces 2018 Fourth Quarter and Full Year Financial and Operational Results Release and Conference Call Date
LEXINGTON, Mass., Feb. 20, 2019 -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical.
- GlobeNewswire•yesterday
Fast Company Names T2Biosystems One of the World’s Most Innovative Companies – For Battling Sepsis in Hours not Days
T2 Biosystems, Inc. (TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, was recognized today by Fast Company among the top 10 of the world’s most innovative companies in the biotech category. The award comes just over 6 months after the launch of the T2Bacteria® Panel, the first and only FDA-cleared test to identify sepsis-causing pathogens directly from whole blood in 3 to 5 hours without the wait for blood culture, which can take 1 to 6 days or more. It is one of several panels that are approved or in development that are run on the Company’s T2Dx® Instrument, which is powered by miniaturized magnetic resonance (T2MR®) technology.
- GlobeNewswire•14 days ago
T2 Biosystems Reports Granting of Inducement Awards
The inducement awards consist of options to purchase 30,500 shares of T2 Biosystems common stock and have a ten-year term. The exercise price of the options is $3.56, which was the per-share closing price of T2 Biosystems common stock on the Nasdaq Capital Market on February 1, 2019.
- GlobeNewswire•29 days ago
T2 Biosystems to Participate in Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
LEXINGTON, Mass., Jan. 23, 2019 -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare,.
- Simply Wall St.•last month
Our Take On T2 Biosystems, Inc.’s (NASDAQ:TTOO) CEO Salary
In 2007 John McDonough was appointed CEO of T2 Biosystems, Inc. (NASDAQ:TTOO). This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we'll Read More...
- Insider Monkey•2 months ago
Is T2 Biosystems Inc (TTOO) Going to Burn These Hedge Funds?
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback […]
- GlobeNewswire•3 months ago
New Research: Key Drivers of Growth for Upland Software, VICI Properties, Sage Therapeutics, Jack Henry & Associates, T2 Biosystems, and Tata Motors — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Nov. 29, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Simply Wall St.•3 months ago
How Many T2 Biosystems Inc (NASDAQ:TTOO) Shares Do Institutions Own?
A look at the shareholders of T2 Biosystems Inc (NASDAQ:TTOO) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies while huge Read More...
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of TTOO earnings conference call or presentation 1-Nov-18 8:30pm GMT
Q3 2018 T2 Biosystems Inc Earnings Call
- Zacks•3 months ago
Zacks.com featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems
Zacks.com featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems
- Zacks•3 months ago
Bet on Rising P/E Investing With These 5 Top-Ranked Stocks
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
- Associated Press•4 months ago
T2 Biosystems: 3Q Earnings Snapshot
On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 25 cents. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...
- Motley Fool•5 months ago
Here's Why T2 Biosystems Rose as Much as 16% Today
The diagnostic innovator provided performance data for a product pipeline candidate aimed at diagnosing Lyme disease.
